Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The United Laboratories International Holdings ( (HK:3933) ) has issued an update.
The United Laboratories International Holdings Limited announced an interim dividend of RMB 0.16 per share for the six months ending June 30, 2025, with the payment to be made in Hong Kong dollars at an exchange rate of RMB 1 to HKD 1.09419. This announcement reflects the company’s ongoing commitment to providing shareholder value and may impact investor sentiment positively as it highlights financial stability and profitability.
The most recent analyst rating on (HK:3933) stock is a Hold with a HK$16.00 price target. To see the full list of analyst forecasts on The United Laboratories International Holdings stock, see the HK:3933 Stock Forecast page.
More about The United Laboratories International Holdings
The United Laboratories International Holdings Limited operates in the pharmaceutical industry, focusing on the production and distribution of antibiotics and other pharmaceutical products. The company is known for its market presence in the Asian region, particularly in Hong Kong and China.
Average Trading Volume: 18,845,767
Technical Sentiment Signal: Buy
Current Market Cap: HK$29.63B
For detailed information about 3933 stock, go to TipRanks’ Stock Analysis page.